Cargando…

Potential therapeutic hazards due to drug–drug interaction between topically and systemically coadministered medications

Detalles Bibliográficos
Autores principales:	Lan, Mei-Juan, Zhou, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753842/ https://www.ncbi.nlm.nih.gov/pubmed/23986640 http://dx.doi.org/10.2147/TCRM.S50375

Ejemplares similares

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects
por: Caltabiano, Stephen, et al.
Publicado: (2018)

Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects
por: Mallikaarjun, Suresh, et al.
Publicado: (2016)

SAT-140 A Drug-Drug Interaction Trial of Oral Semaglutide with Levothyroxine and Multiple Coadministered Tablets
por: Hauge, Camilla, et al.
Publicado: (2019)

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
por: Englund, Gunilla, et al.
Publicado: (2004)

Awareness of Drug–Drug Interaction in Elderly Patients with Osteoarthritis and Depression [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2022)

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans
por: Jakate, Abhijeet, et al.
Publicado: (2020)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Drug-drug Interactions: The Importance of Medication Reconciliation
por: Makiani, Mahin Jamshidi, et al.
Publicado: (2017)

Disease Status–Dependent Drug–Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and Gardenia jasminoides J. Ellis
por: Li, Ziwei, et al.
Publicado: (2021)

Eosinophilic pneumonia: remember topical drugs as a potential etiology
por: Dias, Olívia Meira, et al.
Publicado: (2018)

Innovative electrochemical sensor for the precise determination of the new antiviral COVID-19 treatment Favipiravir in the presence of coadministered drugs
por: Mohamed, Mona A., et al.
Publicado: (2021)

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors
por: Hurtado, Felipe K., et al.
Publicado: (2021)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
por: Brown, Joshua D.
Publicado: (2020)

Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
por: Roesch, Benno, et al.
Publicado: (2013)

Topical finasteride: A potential therapeutic option for hidradenitis suppurativa
por: Manfredini, Marco, et al.
Publicado: (2022)

Occupational hazards due to exposure to waste anesthetic gases
por: Joob, Beuy, et al.
Publicado: (2017)

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study
por: Jakate, Abhijeet, et al.
Publicado: (2021)

Potential interactions between COVID-19 vaccines and antiepileptic drugs
por: Kow, Chia Siang, et al.
Publicado: (2021)

A phototoxic drug reaction due to topical NSAIDs
por: Drivenes, Jakob Lillemoen, et al.
Publicado: (2022)

Drug-induced lung disease due to topical minoxidil
por: Ishiguro, Takashi, et al.
Publicado: (2023)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

Hydroxychloroquine and Potential Drug Interactions in Older Adults
por: Velasco-González, Verónica, et al.
Publicado: (2020)

Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline
por: Tanneau, Lénaïg, et al.
Publicado: (2022)

Dermatosis due to Steroid Exposure: A Startle in Occupational Hazard
por: Nair, Pragya Ashok, et al.
Publicado: (2020)

Safe handling of hazardous drugs
por: Kennedy, Kardi, et al.
Publicado: (2022)

Predictors of drug-drug interactions of medications prescribed to patients admitted due to suicidal behavior
por: Vanzela, Amanda Sarah, et al.
Publicado: (2022)

Exposure to peroxisome proliferators: reassessment of the potential carcinogenic hazard.
por: Roberts, R, et al.
Publicado: (2001)

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Look-Alike Drugs: Avoiding Potential Medical Errors
por: Gangakhedkar, Gauri R., et al.
Publicado: (2019)

Erythema multiforme due to antitubercular drugs
por: Gulati, Sameer, et al.
Publicado: (2011)

Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
por: Vazquez, Sara R., et al.
Publicado: (2022)

Drug-induced ectropion following the chronic use of topical Natamycin
por: Soleimani, Mohammad, et al.
Publicado: (2020)

Assessment of the drug–drug interaction potential for therapeutic proteins with pro‐inflammatory activities
por: Yu, Yanke, et al.
Publicado: (2023)

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
por: Wolff, Jan, et al.
Publicado: (2021)

Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant
por: Barbour, S., et al.
Publicado: (2017)

Drug delivery and nanoparticles: Applications and hazards
por: De Jong, Wim H, et al.
Publicado: (2008)

An unusual potentially hazardous malposition of naostracheal tube
por: Chakravarthy, Murali, et al.
Publicado: (2012)

COVID: A Potential but Preventable Workplace Hazard
por: Malhotra, Nipun, et al.
Publicado: (2020)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
por: Faison, Shamia L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eb9qe5qvc4s9def49u2hu64nn3